What is Divis Laboratories Ltd (DIVISLAB) share price today?

Divis Laboratories Ltd (DIVISLAB) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/DIVISLAB for the latest live price, technical analysis, and AI-powered insights.

How to analyse DIVISLAB stock?

VestAI provides comprehensive DIVISLAB stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Divis Laboratories Ltd in?

Divis Laboratories Ltd (DIVISLAB) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Divis Laboratories Ltd

Name: Divis Laboratories Ltd (DIVISLAB) Financial Metrics
Creator: VestAI
License: https://www.vestai.io/terms

DIVISLAB

NSE· Healthcare

₹8,388.00

+10.00 (+0.12%)

52W Low · ₹5,636.5052W High · ₹8,585.00

Near 52W High

Market Cap

₹213861.48L Cr

Volume

3.17L

Prev Close

₹8,585.00

ISIN

INE361B01024

Orion Score

Fundamentals-based quality & risk · not a recommendation

62/100

Watch

Divis Laboratories Ltd scores 62/100 (Watch) on the Orion Score — strong business quality (77), weak growth (36), strong balance-sheet safety (94) and rich valuation (12). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.9× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 4/9Altman Z Safe(11.59)Beneish M Clean(-2.56)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

69/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.00x — lean balance sheet

QUALITY

Average

ROCE 16.6% — decent returns

MOMENTUM

Bullish

RSI 77.6 — strong momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 83.34
ROCE: 16.56%
ROE (1Y): 16.19%
D/E Ratio: 0.00x
OPM: 28.75%
TTM EPS: ₹96.67
Dividend Yield: 37.00%
Qtrly Sales: ₹2,831.00 Cr
Qtrly Profit: ₹751.00 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹2,831	₹751	28.8%	₹28.31
Q3 2026	₹2,604	₹583	29.6%	₹21.98
Q1 2026	₹2,410	₹545	25.6%	₹20.49
Q4 2025	₹2,585	₹662	30.1%	₹24.93
Q3 2025	₹2,319	₹589	27.8%	₹22.20

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹10,560	₹2,568	₹3,874	28.2%
FY 2025	₹9,360	₹2,191	₹3,320	27.4%
FY 2024	₹7,796	₹1,600	₹2,544	23.5%
FY 2023	₹7,665	₹1,824	₹2,712	26.4%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
DIVISLAB ★	₹2,13,861 Cr	83.34	16.56%	16.19%	0.00x	28.75%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,921 Cr	26.18	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹71,665 Cr	109.91	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,073 Cr	38.07	36.31%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹16,932	₹15,470	₹14,439	₹13,374.71
Equity	₹14,969	₹13,571	₹12,767	₹11,728.18
Total Debt	₹4	₹3	₹4	₹3.69
Cash	₹415	₹363	₹170	₹1,214.76
Net Debt	—	—	—	—
Working Capital	₹8,629	₹8,397	₹8,211	₹7,155.95

Shareholding Pattern

Q1 FY2027

Promoter

52.04%

FII

16.35%

DII

13.37%

Public

18.24%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	52.04% ↓	16.35% ↑	13.37% ↑	18.24% ↓
Q4 FY2026	52.07% ↑	15.86% ↓	12.98% ↓	19.09% ↑
Q3 FY2026	51.88%	20.08% ↑	19.18% ↓	8.75% ↓
Q2 FY2026	51.88%	19.39% ↓	19.68% ↑	8.96% ↓
Q1 FY2026	51.88%	19.74% ↑	18.96% ↓	9.32% ↓
Q4 FY2025	51.89%	18.01% ↑	20.63% ↑	9.39% ↓
Q3 FY2025	51.89%	17.98% ↑	20.44% ↓	9.58% ↓
Q2 FY2025	51.89%	17.25%	20.98%	9.79%

Corporate Actions

Ex-Date	Action	Details
2026-07-24	DIVIDEND	Dividend - Rs 30 Per Share

Smart Money Holdings

Q4 FY2025

Investor	Shares Held	Portfolio %	Change
gic	—	—	—

Funds Holding This Stock

286 mutual fund schemes

PGIM India Healthcare Fund Direct GrowthDHFL_PRAMERICA

10.01%

₹10 Cr

ICICI Prudential Nifty Pharma Index Fund Direct GrowthICICI_PRUDENTIAL

9.48%

₹12 Cr

Bajaj Finserv Healthcare Fund Direct GrowthBajaj Finserv

9.07%

₹30 Cr

ITI Pharma and Healthcare Fund Direct GrowthITI

8.43%

₹20 Cr

DSP Nifty Healthcare Index Fund Direct GrowthDSP

8.12%

₹2 Cr

Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

8.03%

₹248 Cr

HDFC Pharma And Healthcare Fund Direct GrowthHDFC

8.02%

₹189 Cr

Taurus Large Cap Fund Direct GrowthTAURUS

7.93%

₹4 Cr

LIC MF Healthcare Fund Direct GrowthLIC

7.56%

₹7 Cr

SBI Healthcare Opportunities Fund Direct Plan GrowthSBI

6.57%

₹300 Cr

Analyse DIVISLAB with Orion AI

Ask: "Is Divis Laboratories Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Divis Laboratories Ltd (DIVISLAB) Stock

Divis Laboratories Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE361B01024. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.